Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid

Yalcin, M.; Dyskin, E.; Lansing, L.; Bharali, D.; Mousa, S.; Bridoux, A.; Hercbergs, A.; Lin, H.; Davis, F.; Glinsky, G.; Glinskii, A.; Ma, J.; Davis, P.; Mousa, S.

doi:10.1210/jc.2009-1926

Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid

Atıf İçin Kopyala

Yalcin M., Dyskin E., Lansing L., Bharali D. J., Mousa S. S., Bridoux A., ...Daha Fazla

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.95, sa.4, ss.1972-1980, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 95 Sayı: 4
Basım Tarihi: 2010
Doi Numarası: 10.1210/jc.2009-1926
Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1972-1980
Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Context: Tetraiodothyroacetic acid (tetrac) blocks angiogenic and tumor cell proliferation actions of thyroid hormone initiated at the cell surface hormone receptor on integrin alpha v beta 3. Tetrac also inhibits angiogenesis initiated by vascular endothelial growth factor and basic fibroblast growth factor.